Drugs Made In America Acquisition (DMAA) EBITDA (2024 - 2026)

Drugs Made In America Acquisition (DMAA) EBITDA from Jun 30, 2024 to Mar 31, 2026. The TTM Drugs Made In America Acquisition (DMAA) EBITDA is -$530K. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.